Robert Gorab
Orthopaedic Surgery · Orange, CANPI 1326035601
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $13,414,409 of the $13,572,448 with a category attached, or 98.8%. Depuy Synthes Products, Inc. accounts for 99.2% of it on its own, with 7 other manufacturers making up the rest. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $80,310 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$13.5M
- Medical Device Business Services, Inc.$101K
- Johnson & Johnson$638
- Zimmer Biomet$262
- Smith+Nephew$248
- Pacira Pharmaceuticals Incorporated$126
- plus $60 from 2 others
Across 47 payments — averaging $18,909 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$889K
What the payments were for
- Royalty or licence$13,414,40999%
- Consulting fees$147,2631%
- Travel & lodging$8,3860%
- Food & beverage$2,3900%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 108 | $13,470,403 |
| Medical Device Business Services, Inc. | 47 | $100,712 |
| Johnson & Johnson | 7 | $638 |
| Zimmer Biomet | 2 | $262 |
| Smith+Nephew | 2 | $248 |
| Pacira Pharmaceuticals Incorporated | 1 | $126 |
| Pacira Therapeutics, Inc. | 1 | $38 |
| Bioventus LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,572,448 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 52 | $1,036 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $835 |
| Diclofenac Sodium | 83 | $681 |
| Meloxicam | 179 | $534 |
| Oxycodone Hcl | 31 | $222 |
| Amoxicillin | 64 | $153 |
| Tramadol Hcl | 37 | $109 |
| Clindamycin Hcl | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Orange
- Steven BarnettOrange$797K
- Jonah Hebert DaviesOrange$653K
- Bradford HackArcadia$18.3M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Nirav AminPlacentia$5.6M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Peter NewtonSan Diego$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.